Do you have leukemia, lymphoma, MDS, or MF and are preparing for a stem cell transplant from an unrelated donor? If so, you might be eligible to take part in a study that will look look at combinations of medicines given after a stem cell transplant and see how well the combinations work to prevent graft versus host disease and infection.

Do you have metastatic HER2-positive breast cancer? if so you may be able to participate in this research study to find out whether zanidatamab combined with chemotherapy of study doctor's choice is safe and improves on the clinical benefit when compared to trastuzumab in combination with chemotherapy of study doctor's choice in treating the type of breast cancer you have.

If you have Leukemia and are looking for an alternative treatment, you may be eligible to participate in a research study testing a new drug called AUTX-007.

Are you 18 years of age and younger than 75 years old? Do you or do you know someone with Peripheral T-cell Lymphoma? Would you be interested in using your own stem cells versus only using chemotherapy infusions? If you have large cell lymphoma (ALCL) ALK-negative, this study may interest you.

We're testing a new blood test called Multi-Cancer Detection (MCD). This test looks for signs of many types of cancer. We want to learn if it can find cancer early when treatment might work better. Your participation could make a big difference. Thank you for considering joining us!

Do you have pancreatic cancer that is "locally advanced"? This means it can't be removed by surgery, but it hasn't spread elsewhere. Have you recently had chemotherapy, and your tumor has either shrunk or stopped growing? If so, you might be able to join a research study. The study looks at whether adding a high dose of radiation therapy can help people live longer or feel better compared to the usual treatment.

Have you been diagnosed with relapsed or refractory multiple myeloma? If so, you may be able to take part in a research study looking at the safety and tolerability of giving a new drug called ABBV-453 alone and in combination with other antimyeloma drugs to patients with relapsed or refractory multiple myeloma.

Do you speak Spanish or identify as Hispanic or Latino and have cancer? You can help improve cancer care by sharing your experience. We need patients to complete a one-time survey about your health, background, and cancer treatment. Your input is important and can help others receive better care. Participation involves only a one-time survey, with no required medical tests. ¿Es usted un adulto hispano, latino o de habla hispana con cáncer? Puede ayudar a mejorar la atención del cáncer al compartir su experiencia. Le pedimos a los pacientes que completen una encuesta una sola vez sobre su salud, antecedentes y atención médica durante o después del tratamiento. Su voz es importante y puede ayudar a que otros reciban mejor atención. La participación consiste únicamente en una encuesta, sin pruebas médicas obligatorias.

Do you have cancer that has spread to your bones (high-risk bone metastases)? Is your cancer not causing any pain, or asymptomatic? If so, you may be able to take part in a research study comparing the standard approach with the standard approach plus radiation therapy to see if it's better at lowering bone metastases-related complications.

Do you have advanced Stage III or IV Head and Neck Cancer? You might be able to join a research study. We are looking at new treatments compared to the usual care for your type of cancer.